4.5 Article

Effects of Insulin Combined with Idebenone on Blood-Brain Barrier Permeability in Diabetic Rats

期刊

JOURNAL OF NEUROSCIENCE RESEARCH
卷 93, 期 4, 页码 666-677

出版社

WILEY
DOI: 10.1002/jnr.23511

关键词

insulin; idebenone; diabetes; blood-brain barrier; tight junction

资金

  1. Natural Science Foundation of China [81172197, 81072056, 81171131, 81272564, 81272795, 81372484]
  2. Natural Science Foundation of Liaoning Province in China [201102300]
  3. Liaoning Science and Technology Plan Projects in China [2011225020, 2012225016]
  4. Shenyang Science and Technology Plan Projects in China [F13-220-9-15, F13-316-1-16, F13-316-1-19]

向作者/读者索取更多资源

This study investigates the effect of insulin combined with idebenone on blood-brain barrier (BBB) permeability in experimental streptozotocin-induced diabetic rats as well as the underlying mechanisms. With a diabetic rat model, we show that insulin and idebenone normalize body weight and water intake and restore BBB permeability and that their combination displays a synergistic effect. The results from transmission electron microscopy show that the combination of insulin and idebenone significantly closed the tight junction (TJ) in diabetic rats. The results from Western blotting in diabetic rats show that the upregulation of TJ-associated proteins occludin, and zonula occludens (ZO)-1 caused by the combination of insulin and idebenone is more remarkable than that with either agent alone. In addition, the activations of reactive oxygen species (ROS) and advanced glycation end products (AGEs) and the expression levels of receptors for advanced glycation end-products (RAGE) and nuclear factor-B (NF-B) were significantly decreased after treatment with insulin and idebenone in diabetic rats. These results suggest that the combination of insulin and idebenone could decrease the BBB permeability in diabetic rats by upregulating the expression of occludin, claudin-5, and ZO-1 and that the ROS/AGE/RAGE/NF-B signal pathway might be involved in the process. (c) 2014 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据